British Columbia Gazette Part II — B.C. Reg. 156/2009

B.C. Reg. 156/2009

British Columbia — Gazette

British Columbia Gazette Part II — B.C. Reg. 156/2009

B.C. Reg. 156/2009

British Columbia — Gazette

Copyright © Queen's Printer,

Victoria, British Columbia, Canada

Licence

Disclaimer

Volume 52, No. 8

B.C. Reg. 156/2009

The British Columbia Gazette,

Part II

April 21, 2009

B.C. Reg. 156/2009 , deposited April 9, 2009, pursuant to the HEALTH PROFESSIONS ACT [Section 12 (2)]. Ministerial Order M130/2009, dated April 8, 2009.

I, George Abbott, Minister of Health Services, order that the Naturopathic Physicians Regulation, B.C. Reg. 282/2008, is amended as set out in the attached appendix.

— G. ABBOTT, Minister of Health Services .

Appendix

Section 1 of the Naturopathic Physicians Regulation, B.C. Reg. 282/2008, is amended

(

a) by repealing the definition of "naturopathic medicine" and substituting the following:

"naturopathic medicine" means the health profession in which a person provides the services of prevention, assessment and treatment of an individual's diseases, disorders and conditions using education and naturopathic techniques, therapies or therapeutics to stimulate or support healing processes and promote, maintain or restore the overall health of the individual; , and

(

b) by adding the following

definitions:

"compound" means

(

a) in respect of a drug, to mix with one or more other ingredients, and

(

b) in respect of a therapeutic diet, to mix two or more ingredients;

"dispense" has the same meaning as in the Pharmacy Operations and Drug Scheduling Act , but excludes a sale, as defined in that Act;

"drug" means, except in the definition of "substance", a drug

(

a) specified in

Schedule I of the Drug Schedules Regulation, B.C. Reg. 9/98, other than a drug set out in the

Schedule of this regulation, or

(

b) specified in

Schedule II of the Drug Schedules Regulation;

"enteral instillation" means instillation directly into the gastrointestinal tract;

"minor surgery" means a surgical procedure that

(

a) is performed, for a diagnostic or therapeutic purpose, on a superficial anatomical structure, and

(

b) does not involve

(

i) sedation, general anaesthesia or respiratory assistance, or

(ii) a material risk to life;

"parenteral instillation" means instillation directly into the blood stream;

"prescribe" means to issue a prescription, as defined in the Pharmacy Operations and Drug Scheduling Act ;

"substance" includes air and water, but excludes a drug specified in

Schedule I, IA, II or IV of the Drug Schedules Regulation.

Section 5 is repealed and the following substituted:

Restricted activities

(1) A registrant in the course of practising naturopathic medicine May do any of the following:

(

a) use naturopathic techniques to make a diagnosis identifying, as the cause of signs or symptoms of an individual, a disease, disorder or condition;

(

b) perform a procedure on tissue

(

i) below the dermis, or

(ii) below the surface of a mucous membrane;

(

c) move a joint of the spine beyond the limits the body can voluntarily achieve but within the anatomical range of motion using a high velocity, low amplitude thrust;

(

d) administer a substance

(

i) by injection,

(ii) by inhalation,

(iii) by irrigation,

(iv) by enteral instillation or parenteral instillation, or

(

v) using a hyperbaric chamber;

(

e) put an instrument or a device or finger

(

i) into the external ear canal, up to the eardrum,

(ii) beyond the point in the nasal passages where they normally narrow,

(iii) beyond the opening of the urethra,

(iv) beyond the labia majora,

(

v) beyond the anal verge, or

(vi) into an artificial opening into the body;

(

f) put into the external ear canal, up to the eardrum, a substance that is under pressure;

(

g) apply

(

i) ultrasound for diagnostic or imaging purposes, including any application of ultrasound to a fetus,

(ii) electricity for the purposes of

(

A) destroying tissue in the course of minor surgery, or

(

B) defibrillation in the course of emergency cardiac care, or

(iii) X-rays for diagnostic or imaging purposes, excluding X-rays for the purpose of computerized axial tomography;

(

h) issue an instruction or authorization for another person to perform, in respect of a named individual, a restricted activity specified in paragraph (g) (

i) or (iii);

(

i) in respect of a drug,

(

i) prescribe the drug,

(ii) compound the drug,

(iii) dispense the drug, or

(iv) administer the drug by any method;

(

j) if nutrition is administered by enteral instillation or parenteral instillation,

(

i) select ingredients for a therapeutic diet,

(ii) compound a therapeutic diet, or

(iii) dispense a therapeutic diet;

(

k) conduct challenge testing for allergies

(

i) that involves injection, scratch tests or inhalation, if the individual being tested has not had a previous anaphylactic reaction, or

(ii) by any method, if the individual being tested has had a previous anaphylactic reaction;

(

l) conduct desensitizing treatment for allergies

(

i) that involves injection, scratch tests or inhalation, if the individual being tested has not had a previous anaphylactic reaction, or

(ii) by any method, if the individual being tested has had a previous anaphylactic reaction.

(2) Only a registrant May practise naturopathic medicine.

Section 6 is repealed and the following substituted:

Limits or conditions on services and restricted activities

(1) A registrant May perform only surgery that is minor surgery.

(2) A registrant May prescribe, compound, dispense or administer a drug only if

(

a) standards, limits and conditions have been established, under

section 19 (1) (

k) or (

l) of the Act, respecting the prescribing, compounding, dispensing and administering of drugs by registrants,

(

b) the standards, limits and conditions described in paragraph (

a) are established on the recommendation of a committee that

(

i) is established under

section 19 (1) (

t) of the Act, and

(ii) has the duty and power to develop, review and recommend those standards, limits and conditions, and

(

c) the registrant has successfully completed a certification program established, required or approved under the bylaws to ensure that registrants are qualified and competent to prescribe, compound, dispense or administer a drug.

(3) A registrant May perform an activity described in

section 5 (1) (d) (v), (

k) or (

l) only if

(

a) standards, limits and conditions have been established, under

section 19 (1) (

k) or (

l) of the Act, respecting the activity, and

(

b) the standards, limits and conditions described in paragraph (

a) are established on the recommendation of a committee that

(

i) is established under

section 19 (1) (

t) of the Act, and

(ii) has the duty and power to develop, review and recommend those standards, limits and conditions.

4 The following

Schedule is added:

Schedule

Excluded

Schedule I Drugs

Acetohexamide

Adalimumab

Adefovir

Agalsidase alfa

Aldesleukin

Alemtuzumab

Alfentanil

Alkyl nitrites

Alprazolam

Altretamine

Amifostine and its salts

Aminoglutethimide

Aminopterin and its salts

Aminopyrine and its derivatives

Amprenavir and its salts and derivatives

Amsacrine and its salts

Anagrelide and its salts

Anakinra and its salts and derivatives

Anastrozole

Ancestim

Anileridine

Anti-thymocyte globulin

Atazanavir and its salts

Atracurium besilate

Auranofin

Aurothioglucose

Basiliximab

Bevacizumab

Bicalutamide

Bleomycin

Bortezomib

Bromazepam and its salts

Buprenorphine

Buserelin and its salts

Busulfan

Butalbital

Butorphanol

Cabergoline and its salts

Capecitabine and its salts and derivatives

Carboplatin

Carmustine

Cetrorelix and its salts

Cetuximab

Chlorambucil and its salts and derivatives

Chlordiazepoxide and its salts

Chlorisondamine and its salts

Choriogonadotripin alfa

Cinacalcet and its salts

Cisplatin

Cladribine and its salts

Clobazam and its salts

Clonazepam and its salts

Clorazepic acid and its salts

Codeine when prescribed as a single entity or when included in a preparation containing 60 mg or more per dosage unit

Cyclophosphamide

Cycloserine

Cyclosporine

Cytarabine and its salts

Dacarbazine

Daclizumab

Dactinomycin

Daunorubicin and its salts

Delavirdine and its salts

Desflurane

Dexrazoxane and its salts

Diazepam and its salts

Didanosine and its salts and derivatives

Diethylstilbestrol and its derivatives

Dihydrotachysterol

Dinoprostone and its salts and derivatives

Docetaxel and its derivatives

Doxacurium chloride

Doxercalciferol and its derivatives

Doxorubicin and its salts

Droperidol and its salts

Edrophonium chloride

Efavirenz

Emtricitabine

Enflurane

Enfuvirtide

Epirubicine and its salts

Erythropoietin

Estazolam and its salts

Estramustine and its salts

Etanercept

Ethambutol and its salts

Ethchlorvynol

Ethionamide and its salts

Ethoheptazine and its salts

Etoposide and its derivatives

Exemestane

Fenfluramine and its salts

Fentanyl

Filgrastim

Flucytosine

Fludarabine and its salts and derivatives

Flumazenil

Fluorouracil and its derivatives for parenteral use only

Flurazepam and its salts

Flutamide

Follicle stimulating hormone

Formestane and its salts and derivatives

Fulvestrant

Gallamine triethiodide

Ganirelix and its salts and derivatives

Gefitinib

Gemcitabine and its salts

Glatiramer and its salts

Gold and its salts

Goserelin and its salts

Halazepam and its salt

Halofantrine and its salts

Halothane

Hydrocodone (dihydrocodeinone)

Hydromorphone (dihydromorphone)

Hydroxychloroquine and its salts

Idarubicin and its salts

Ifosfamide

Imatinib and its salts

Imiglucerase

Indinavir and its salts

Infliximab

Interferon

Iproniazid and its salts

Irinotecan and its salts

Isoflurane

Ivermectin and its derivatives

Kanamycin and its salts and derivatives

Ketamine and its salts

Ketazolam and its salts

Lamivudine and its salts

Laronidase

L-Asparaginase

Leflunomide and its salts

Letrozole

Leuprolide and its salts

Levallorphane and its salts

Levamisole and its salts

Levorphanol

Lincomycin and its salts and derivatives

Linezolid and its salts

Lomefloxacin and its salts

Lomustine

Lopinavir

Loracarbef and its salts and derivatives

Lorazepam and its salts

Mazindol and its salts

Mecamylamine and its salts

Mechlorethamine and its salts

Melanoma therapeutic vaccine

Melphalan

Menotropins (human)

Meperidine (pethidine)

Mercaptopurine

Meropenem and its salts and derivatives

Mesna

Metaraminol bitartrate

Methadone

Methaqualone

Midazolam and its salts

Midodrine and its salts

Miglustat

Mitomycin and its salts

Mitotane (o,p'-DDD)

Mitoxantrone and its salts

Mivacurium chloride

Molgramostim

Morphine

Muromonab-CD3

Mycophenolic acid and its salts and derivatives

Nalmefene and its salts

Nelfinavir and its salts

Neostigmine salts

Netilmicin and its salts and derivatives

Nevirapine and its salts

Nikethamide

Nilutamide

Nitrazepam and its salts

Normethadone

Octreotide

Oxazepam and its salts

Oxycodone

Paclitaxel and its derivatives

Palivizumab

Pamidronic acid and its salts

Pancuronium and its salts

Pegfilgrastim

Pemetrexed and its salts

Pentamidine and its salts

Pentazocine

Pentolinium tartrate

Pentostatin and its salts

Perflutren

Phentolamine and its salts

Pipobroman

Porfimer and its salts

Pralidoxime and its salts

Prazepam and its salts

Prodilidine and its salts

Propofol

Propoxyphene

Pyrazinamide

Pyridostigmine bromide

Raltitrexed and its salts and derivatives

Rasburicase

Rifabutin and its salts

Riluzole and its salts

Ritonavir

Rituximab

Rocuronium bromide

Rofecoxib

Saquinavir and its salts and derivatives

Sargramostin

Sevelamer hydrochloride

Sirolimus and its derivatives

Sodium aurothiomalate

Stavudine

Streptozocin

Succinylcholine and its salts

Sufentanil

Suxamethonium chloride

Tacrolimus and its derivatives

Tegafur and its salts

Temazepam and its salts

Temozolomide and its salts

Teniposide

Tenofovir and its salts and derivatives

Thalidomide

Thiocarlide

Thioguanine

Thiotepa

Tiludronic acid and its salts

Tipranavir and its salts

Topotecan and its salts

Toremifene and its salts

Trastuzumab

Treosulfan

Treprostinil and its salts

Tretamine

Triazolam and its salts

Trimethaphan camsylate

Trimetrexate and its salts

Troglitazone

Tubocurarine and its salts

Valrubicin and its derivatives

Vecuronium bromide

Viomycin and its salts and derivatives

Zalcitabine and its salts

Zidovudine

Zoledronic acid and its salts and derivatives

Copyright © 2009: Queen's Printer, Victoria, British Columbia, Canada

Document details

CollectionBritish Columbia — Gazette
CitationB.C. Reg. 156/2009
Typegazette
Volume / chapterbcgaz2 v52n08 156 2009
Languageen
Formatxml
SourcePROVINCIAL
Identifier649b1e3e5780896ac3ae4c5deedcda0681d1f3ec

Source file is stored in the law ingest library (xml).